ReleaseWire Connect

EV traction motor is an electric motor that is used for the propulsion of EVs. It converts electrical energy into motion. These traction motors form a major component in EVs such as cars, two-wheelers, light industrial/commercial vehicles, military vehicles, buses, and others. These motors determine the performance and affordability of EVs.

Emulsion coatings contain small groups or clusters of insoluble resin particles suspended in water. Organic solvents in small quantities are used as coalescing agents for proper film formation.

The Future of the Saudi Arabian Defense Industry – Market Attractiveness, Competitive Landscape and Forecasts to 2020 published by Strategic Defence Intelligence, provides readers with a detailed analysis of both historic and forecast Saudi Arabian defense industry values, factors influencing demand, the challenges faced by industry participants, analysis of industry leading companies, and key news.

Genomic Health, Inc. (Genomic Health) is a provider of genomic-based clinical laboratory services for the treatment of cancer. The companys commercial product portfolio comprises Onco type DX breast cancer test, Onco type DX colon cancer test, and Onco type DX prostate cancer test. It conducts extensive research and development activities to optimize the treatment of urologic cancers including prostate, bladder, and kidney cancers, and additional treatment decisions in breast and colon cancers. Genomic Health develops these products using its Onco type DX platform, a technology which uses RT-PCR approach to improve cancer treatment decisions. The company operates along with its subsidiaries in over 30 countries including the UK, Germany, France, Ireland, Italy, Japan, the Netherlands, Canada, and the US. Genomic Health is headquartered in Redwood City, California, the US.The company strives to offer personalized care for the UK breast cancer patients. To this end, Genomic Health announced the availability of Onco type DX test to the eligible breast cancer patients through the National Health Service (NHS) in England effective April 01, 2015.

Cepheid is a molecular diagnostic company. It offers tests, reagents, and systems for testing in clinical and non-clinical markets. The company's flagship product, GeneXpert system incorporates sample preparation, nucleic acid extraction and purification, DNA amplification, and detection into a minute, self-contained cartridge. This system facilitates 24/7 rapid molecular testing. Its SmartCycler system integrates DNA amplification and detection for real-time rapid batch or random access analysis. Cepheid also offers GeneXpert system in the areas of GeneXpert system in clinical areas such as healthcare-associated infections, critical infectious disease, sexual health, virology, oncology, womens health, and genetics. It also offers GeneXpert modules integrated into the biohazard detection systems (BDS) using its Bacillus anthracis test, and SmartCycler system along with general use PCR reagents and reaction tubes. The company operates along with its subsidiaries in France, Sweden, the US, Japan, Germany, South Africa, the UK, Belgium, Australia, the UAE, China, Italy, Singapore, Brazil, India, and Hong Kong. Cepheid is headquartered in Sunnyvale, California, the US.The company plans to expand its Xpert product portfolio. To this end, Cepheid collanorated with Rutgers and the Foundation for Innovative New Diagnostics (FIND) to develop Xpert MTB/RIF ultra, a next-generation test for Mycobacterium tuberculosis.

Autoimmune Technologies, LLC (Autoimmune) is a biomedical company that develops medical diagnostic tests, explores disease mechanisms and investigates therapies for autoimmune diseases and disorders. Its laboratory tests include fibromyalgia, lassa fever, gulf war syndrome, lupus, juvenile RA, graves' disease, breast cancer and non-HIV aids. Autoimmune conducts research in the areas of influenza drugs, fibromyalgia syndrome, systemic lupus erythematosus, juvenile rheumatoid arthritis, gulf war syndrome, breast cancer, graves' disease, non-HIV aids, and lassa fever. Autoimmune is headquartered in New Orleans, Louisiana, the US.

Atlas Genetics Ltd (Atlas Genetics) is an in vitro diagnostics company that concentrates on decentralised, near-patient and point of care (POC) testing. The company develops and offers diagnostic platforms such as io System and Callisto System. Its io system is a diagnostic instrument and disposable cartridge system which is designed for POC testing services to provide accurate solution to screening for the presence of STIs and HAIs. The company's products and solutions are used in the diagnosis of sexually transmitted infections, neonatal sepsis, and hospital acquired infection. Atlas Genetics is headquartered in Trowbridge, the UK.

Thoratec Corporation (Thoratec) is a medical device company. It undertakes the research, development, manufacture and marketing of proprietary medical devices used for mechanical circulatory support for the treatment of heart failure (HF) patients. The major product of the company includes Thoratec Paracorporeal Ventricular Assist DeviceThoratec Implantable Ventricular Assist DeviceHeartMate Left Ventricular Assist Systemand HeartMate II Left Ventricular Assist System. The company also offers acute circulatory support products including CentriMag acute circulatory system and PediMag/PediVAS pediatric acute circulatory system. Thoratecs products are marketed and sold in the US, Europe, Japan and other countries. The company markets its products to heart transplant hospitals and large cardiac surgery centers. Thoratec is headquartered in California, the US.

NuVasive, Inc. (NuVasive) is a medical device company. It offers an extensive selection of minimally-disruptive surgical products, and procedurally-integrated solutions for the spine. The companys product portfolio focuses on spine fusion surgery including cervical surgery and thoracolumbar surgery. NuVasives principal product offering includes a minimally-disruptive surgical platform, namely, maximum access surgery (MAS). Under this platform, the company offers three categories of solutions, nerve detection and avoidance systems, intra-operative monitoring (IOM) services and supportand MaXcess, an integrated split-blade retractor system, and various specialized implants and biologics. These products facilitate surgeons access to the spine to perform restorative and fusion procedures in a minimally-disruptive fashionand aid in spinal fusion or bone healing process. The company offers its products in various markets across the Americas, Asia-Pacific, and Europe. NuVasive is headquartered in San Diego, California, the US.

Quest Diagnostics Incorporated (Quest Diagnostics) is a medical diagnostics company. It offers diagnostic testing services to patients and physicians through a chain of laboratories and company-owned patient service centers. The company offers comprehensive services such as clinical testing, with gene-based and other esoteric tests, anatomic pathology services, life insurer services, clinical trial testing, healthcare information technology, and diagnostic products. Quest Diagnostics, along with its subsidiaries and branches, operates in India, Ireland, Mexico, Sweden, the UK, the US, Singapore, China, South America and Australia. Quest Diagnostics is headquartered in Madison, New Jersey, the US.The company intends to grow through acquisitions. To this end, in August 2014, Quest acquired the remainder of Steward Health Care System LLCs outreach laboratory service operations.